Agarwal, T., N. Annamalai, H. P. Ronanki, S. Butty, T. K. Maiti, and H. B. Arsad. “MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 11, no. 2, Dec. 2018, pp. 59-64, doi:10.22159/ijpps.2019v11i2.30577.